Finalised programme and meeting booklet for the meeting. It’s going to be a good one!
| 13:30-14:00 | Debate: This house does not accept the recent NICE guidelines that radioactive iodine is the first line treatment for Graves’ disease For: Dr Price / Against: Dr Premawardhana |
| 14:00-14:05 | Diabetes Clinic@home Project Professor Stephen Bain |
| 14:05-14:17 | Isolated splenic sarcoidosis: a rare cause of hypercalcaemia Dr Hafiz Muhammad Zubair Ullah, University Hospital of Wales |
| 14:17-14:29 | Anti-glutamic acid decarboxylase antibody (GAD-ab)-associated cerebellar ataxia and haemorrhage in autoimmune polyglandular syndrome Type 3 Dr Erneda Gatdula, Glan Clwyd Hospital |
| 14:29-14:41 | Dexamethasone measurement as part of the overnight Dexamethasone suppression test: a Cardiff and Vale perspective Dr Sarah Tennant, University Hospital of Wales |
| 14:41-14:53 | Glycaemic disturbances after pancreas transplantation Dr Weronika Kozuch, University Hospital of Wales |
| 14:53-15:05 | SEREN Connect – A Holistic Young Adult Diabetes Education Programme Sara Crowley |
| 15:05-15:17 | Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma Dr Fred Keen, Royal Glamorgan Hospital |
| 15:17-15:29 | Technology in improving patient outcomes. Alison Ellis, University Hospital of Wales |
| 15:29-15:41 | Dexamethasone in Hospitalized Patients with Covid-19: A Prospective Pilot Study Dr Mohammad Alhadj Ali, University Hospital of Wales |
| 15:41-15:45 | DKA Awareness Dr Steve Stanaway |
The organisers would like to thank the following companies for their sponsorship of the meeting:
No pharmaceutical companies have had any input into the agenda. Pharmaceutical companies have sponsored the meeting through purchase of slide space on the zoom meeting, and on the WEDS Website and acknowledgement of sponsorship shown on the printed Programme.
